SlidesetHIVLatest Estimates for Pediatric/Adolescent HIV Prevalence and Coverage- Mary Mahy, ScD, MHScView Slideset
SlidesetHIVWhat Have We Learned from the ACT Initiative – identifying and treating children with HIV infection- George Siberry, MD, PhDView Slideset
SlidesetHIVThe Hidden Pediatric HIV Epidemic in Eastern Europe- Natella Rakhmanina, MD, PhD, FAAP, FCP, AAHIVSView Slideset
SlidesetHIVDebate: Integrase Inhibitor-based ART should be first-line therapy for children- Albert Faye, PhDView Slideset
SlidesetHIVChallenges and Triumphs of Pediatric HIV Care and Treatment in West/Central Africa- Didier Ekouevi, MD, PhDView Slideset
SlidesetHIVDebate: Integrase Inhibitor-based ART should be first-line therapy for children- Victor Musiime, MBChB, MMED, PhDView Slideset
SlidesetHIVComparing Conventional to Point-of-Care (POC) Early Infant Diagnosis (EID): Pre and post intervention data from a multi-country evaluation- Dr. Jennifer CohnView Slideset
SlidesetHIVVirological dynamics in HIV-infected infants following very early antiretroviral treatment- Dr. Renate StrehauView Slideset
SlidesetHIVCharacteristics and outcomes of infants initiating early antiretroviral therapy in South Africa, 2006-2016 – The International epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration.- Dr. Victoria IyunView Slideset
SlidesetHIVAge-stratified rates of mortality and key clinical events in youth aged 0-24 years in the multiregional IeDEA network- Dr. Sophie DesmondeView Slideset
SlidesetHIVIncidence of virological failure to first-line ART among children in Europe and Thailand- Dr. Ruth GoodallView Slideset
SlidesetHIVMulti-month prescription of antiretroviral therapy and its feasibility - experiences from the Baylor International Pediatric AIDS initiative (BIPAI) in six Southern African countries- Dr. Maria KimView Slideset
SlidesetHIVUsing Infant Animal Models to Advance Pediatric HIV Prevention, Vaccines and Cure- Ann Chahroudi, MD, PhDView Slideset
SlidesetHIVCase Management of Mycobacterial Infections//HIV - High Resource Country- Gareth Tudor-Williams, MDView Slideset
SlidesetHIVCase Management of Mycobacterial Infections//HIV - Low Resource Country- Linda Barlow-Mosha, MD, MPHView Slideset
SlidesetHIVStructured and Culturally-Relevant Disclosure Intervention Improves Pediatric HIV Disclosure in Ghana: The SANKOFA Experience- Dr. Elijah PaintsilView Slideset
SlidesetHIVViral Hepatitis Mother-to-Child Transmission: Applying Lessons from HIV to HBV/HCV- Monique Andersson, MRCP, FRCPathView Slideset
SlidesetHIV"Growth evolution and stunting among HIV-infected adolescents in the multiregional IeDEA cohort consortium"- Dr. Julie JessonView Slideset
SlidesetHIVStructural brain changes and associations in perinatally infected younger adolescents in CTAAC- Dr. Jacqueline HoareView Slideset
SlidesetHIVEarly clinical and social outcomes at and after transfer from pediatric to adult HIV care in Asia- Dr. Annette SohnView Slideset
SlidesetHIVImpacts of vitamin D and calcium supplementation on bone mineral density among perinatally HIV-infected adolescents: A 48-week randomized clinical trial- Dr. Tavitiya SudjaritrukView Slideset
SlidesetHIVDoes HIV-Related Vascular Disease Gradually Improve with Accumulating Time on ART? Data from CHER- Dr. Steven InnesView Slideset
SlidesetHIVA Last Barrier to eMTCT: Acute HIV Infection in Pregnancy/Breastfeeding- Alison Drake, MPH, PhDView Slideset
SlidesetHIVPregnancy and Neonatal Outcomes following Prenatal Exposure to Dolutegravir- Dr. Claire ThorneView Slideset
SlidesetHIVIntensification of antiretroviral treatment with raltegravir for late-presenting HIV-infected pregnant women- Dr. Thanyawee PuthanakitView Slideset
SlidesetHIVIs Tenofovir Use in Pregnancy Associated with Preterm Delivery? A Canadian Perinatal HIV Surveillance Program Analysis- Dr. Jason BrophyView Slideset
SlidesetHIVAsymptomatic Hematologic Toxicity Associated with Very Early Combination Antiretroviral Therapy (cART) in In Utero HIV-infected Infants- Dr. Ellen ChadwickView Slideset
SlidesetHIVHepatotoxicity in HIV+ Postpartum Women Initiating Efavirenz-Containing Regimens- Dr. Patricia FlynnView Slideset
SlidesetHIVThe population effect of HIV exposure in HIV-uninfected children on infant mortality in Botswana and South Africa- Dr. Amy SlogroveView Slideset
SlidesetHIVDevelopmental outcomes of breastfed, HIV-exposed uninfected and breastfed, HIV-unexposed children in the context of universal maternal antiretroviral therapy: a prospective cohort-Dr. Stanzi Le RouxView Slideset
SlidesetHIVHIV -Affected but Not Infected – The Dilemma of HIV-Exposed but Uninfected Infants- Kathleen Powis, MD, MPH, MBAView Slideset
SlidesetHIVThe Second Generation: Pregnancy in Perinatal HIV Infected Women- Jennifer Jao, MD, MPHView Slideset
SlidesetHIVAttrition and treatment outcomes among perinatally and behaviourally HIV-infected adolescents and youths in Thai National AIDS program- Dr. Sirinya TeeraananchaiView Slideset
SlidesetHIVExperiences of transition to adult care and readiness to self-manage care in young people with perinatal HIV in England- Dr. Ali JuddView Slideset
SlidesetHIVWhat constitutes adolescent-friendly health services? Clinic characteristics that attenuate internalised HIV stigma among adolescents living with HIV- Dr. Marija PantelicView Slideset
SlidesetHIVDebate: Self-testing should be implemented for all adolescents - Pro- Cheryl JohnsonView Slideset
SlidesetHIVDiscussion: What constitutes “Adolescent Friendly” Programming?- Nicola Willis, MPhilView Slideset
SlidesetHIVDiscussion: What constitutes “Adolescent Friendly” Programming?- Claude Mellins, PhDView Slideset
SlidesetHIVDebate: Self-testing should be implemented for all adolescents - Con- Gabriel Chamie, MDView Slideset
SlidesetHIVDiscussion: What constitutes “Adolescent Friendly” Programming?- Catherine Dollfus, MD, MPHView Slideset
